Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Tamsulosin and Tadalafil in Healthy Males
NCT02247518Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Sep 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tadalafil and tamsulosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoints: Area Under the Curve to the last measurable concentration and Maximum Plasma Concentration. Started Sep 2014; status: completed.
02
Drugs
tadalafiltamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02247518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247518.